These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 7028534

  • 41. Clavulanic acid inhibits beta-lactamases.
    FDA Drug Bull; 1984 Dec; 14(3):25. PubMed ID: 6335441
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [The development of bacterial resistance and the role of clavulanic acid].
    Rolinson JN.
    Antibiot Khimioter; 1992 Sep; 37(9):11-4. PubMed ID: 1444658
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis.
    Beghi G, Berni F, Carratù L, Casalini A, Consigli G, D'Antò M, Gioia V, Molino A, Paizis G, Vaghi A.
    J Chemother; 1995 Apr; 7(2):146-52. PubMed ID: 7666122
    [Abstract] [Full Text] [Related]

  • 46. Combined attack.
    Wenz C.
    Nature; 1995 Apr; 293(5829):178. PubMed ID: 6974308
    [No Abstract] [Full Text] [Related]

  • 47. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the field of otorhinolaryngology].
    Kawamura S, Sugita R, Fujimaki Y, Deguchi K.
    Jpn J Antibiot; 1983 Mar; 36(3):500-8. PubMed ID: 6553606
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Extended release amoxicillin/clavulanate: optimizing a product for respiratory infections based on pharmacodynamic principles.
    Jacobs MR.
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):353-60. PubMed ID: 15954852
    [Abstract] [Full Text] [Related]

  • 51. Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis.
    Siempos II, Dimopoulos G, Korbila IP, Manta K, Falagas ME.
    Eur Respir J; 2007 Jun; 29(6):1127-37. PubMed ID: 17301097
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Effect of BRL 25000 (clavulanic acid-amoxicillin) on bacterial flora in human feces].
    Motohiro T, Tanaka K, Koga T, Shimada Y, Tomita N, Sakata Y, Fujimoto T, Nishiyama T, Kuda N, Ishimoto K.
    Jpn J Antibiot; 1985 Feb; 38(2):441-80. PubMed ID: 3847525
    [Abstract] [Full Text] [Related]

  • 60. Comparison of the efficacy of amoxicillin-clavulanic acid, cefovecin, and doxycycline in the treatment of upper respiratory tract disease in cats housed in an animal shelter.
    Litster AL, Wu CC, Constable PD.
    J Am Vet Med Assoc; 2012 Jul 15; 241(2):218-26. PubMed ID: 22765368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.